Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis
Imen Akkari1, Hanen Akkari2, Raida Harbi3
1Department of Gastroenterology, University Hospital of Hached, University of Sousse, Faculty of Medicine of Sousse, Sousse 4000, Tunisia. imenakkaribm@gmail.com.
None:
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. The primary risk factor for HCC is cirrhosis. Identifying individuals who are at high risk of developing HCC will have numerous benefits for patient outcomes, patient quality of life, and the global healthcare system. Artificial intelligence (AI) has the capability to develop systems that emulate human intelligence. Recent studies have highlighted the potential of AI in the management of HCC, and the application of AI appears promising for identifying high-risk groups among patients with cirrhosis who require closer monitoring. Ultimately, the aim of AI in the field of HCC clinical care is to enable earlier diagnosis and consequently improve prognosis.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
